首页> 外文期刊>International Journal of Biomedical and Pharmaceutical Sciences. >Formulation and Evaluation of Microemulsions-Based Drug Delivery System for Intranasal Administration of Olanzapine
【24h】

Formulation and Evaluation of Microemulsions-Based Drug Delivery System for Intranasal Administration of Olanzapine

机译:基于微乳的奥氮平鼻内给药系统的设计与评价

获取原文
获取原文并翻译 | 示例
       

摘要

This paper describes formulation considerations and in vitro evaluation of an oleic acid-based polyelectrolytic polymer-containing microemulsion drug delivery system designed for intranasal administration of a hydrophobic model drug Olanzapine. Drug-loaded microemulsions were successfully prepared by a water titration method. The microemulsion containing 4% oleic acid, 30% surfactant mixture of Labrasol: Cremophor RH 40 (1:1) : Transcutol P (3:1) and 66% (wt/wt) aqueous phase that displayed an optical transparency 99.93%, globule size 25.67 +- 1.17 ran, and polydispersity index of 0.121 +- 0.016 was selected for the incorporation of polyelectrolytic polymer (polycarbophil) as the mucoadhesive component. The mucoadhesive microemulsion formulation of Olanzapine that contains 0.5% polycarbophil (w/w) displayed higher in vitro mucoadhesive potential (19.0 +- 2.0 min) and diffusion coefficient (1.40 x 10'6 +- 0.019 x 10"6) than the microemulsion, followed Higuchi model, was free from nasal ciliotoxicity and stable for six months.
机译:本文介绍了一种设计用于鼻内给药疏水性模型药物奥氮平的油酸基含聚电解质聚合物的微乳液药物递送系统的制剂注意事项和体外评估。通过水滴定法成功制备了载药微乳剂。包含4%油酸,30%Labrasol:Cremophor RH 40(1:1):Transcutol P(3:1)和66%(wt / wt)水相的表面活性剂混合物的微乳液,显示出光学透明性99.93%,球状尺寸为25.67±1.17nm,并且选择多分散指数为0.121±0.016用于掺入聚电解质聚合物(聚卡波非)作为粘膜粘附组分。含有0.5%聚卡波非(w / w)的奥氮平粘膜粘附微乳剂比微乳剂具有更高的体外粘膜粘附电位(19.0 +-2.0 min)和扩散系数(1.40 x 10'6 +-0.019 x 10“ 6),遵循Higuchi模型,没有鼻纤毛毒性,并且稳定了六个月。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号